INTRODUCTION
Shigellosis, or bacillary dysentery, is a bloody diarrhea caused by the invasion of the human colonic and rectal mucosa by Shigella, a gramnegative microorganism belonging to the family enterobacteriaceae. In the developing world, children are the major victims with 600,000 deaths every year. The symptoms are characterized by early watery diarrhea rapidly followed by fever, intestinal cramps, and emission of mucopurulent and bloody stools. Immediate complications may occur, such as hypoglykemia, seizure, toxic megacolon, and the hemolytic uremic syndrome (HUS). A chronic enteropathy may also be observed with delayed thriving of affected children. There are four species of Shigella (Shigella sonnei, Shigella flexneri, Shigella dysenteriae and Shigella boydii). The worldwide endemic form of the disease is caused by S. sonnei and S. flexneri. The epidemic form, which accounts for deadly outbreaks in developing areas, is caused by S. dysenteriae 1. The latter, which was discovered in 1898 by the Japanese microbiologist Shiga, is still often referred to as the Shiga bacillus. It is characterized by the production of Shiga toxin, a potent cytotoxin accounting for the particular severity of the cases the Shiga bacillus usually causes. Shigella is a highly contagious microorganism which is transmitted directly from person to person by hand contact, or indirectly by contaminated food or water. High infectious capacity and rapid occurrence of multiple resistance to antibiotics make prevention and treatment of shigellosis a difficult task. No vaccine is yet available.
A key factor of the pathogenesis of shigellosis is the capacity of the causative microorganisms to invade epithelial cells (LaBrec, 1965) . Based S69 on in vitro assays, invasion encompasses three major steps: the capacity of bacteria to induce their own entry into epithelial cells by macropinocytosis (Clerc, 1987) , their property to lyse the membrane of the endocytic vacuole and to escape into the cytoplasm (Sansonetti, 1986) , their capacity to move intracellularly and to spread from cell to cell (Makino, 1986) by an actin-dependent process (Bernardini, 1989) . This capacity of Shigella to interact with components of the eukaryotic cell, particularly its cytoskeleton, is a remarkable example of molecular cross-talk between a pathogen and its target cell. The signals allowing actin nucleation-polymerization and cytoskeletal rearrangements are currently deciphered. Two major signalling pathways have been shown to be activated during Shigella entry. The protooncogene pp60 c-src is recruited at the entry site and its activation allows the tyrosinephosphorylation of one of its major substrates, cortactin (Dehio, 1995 Suzuki, 1996) . vinculin has been shown to interact in vitro with IcsA by its globular head domain. Recruitement of vinculin at the pole of Shigella occurs before substantial accumulation of F-actin occurs. VASP, another focal adhesion protein is a ligand for ActA (Niebuhr, 1993) and for vinculin (Reinhard, 1996) , suggesting that Listeria and Shigella have evolved similar motility mechanisms involving VASP and an ActA analog, vinculin.
When the moving organism reaches the inner face of the cytoplasmic membrane, a protrusion is formed which is absorbed by the adjacent cell (Prevost, 1992; Sansonetti, 1994) . Interactions are established with components of the cellular junction which allow this passage into the adjacent cell. Expression of cadherins is required to allow absorbtion of these protrusions by adjacent cells (Sansonetti, 1994) . Once in the adjacent cell, the bacteria are trapped inside a double-membrane bound pocket which is rapidly lysed, involving IcsB, a 57 kDa protein which is encoded by a gene located upstream the ipa genes in the locus encoding the effectors of entry (Allaoui, 1992).
APOPTOTIC KILLING OF MACROPHAGES BY S. FLEXNERI: ANOTHER EXPRESSION OF THE INVASIVE PHENOTYPE AND A LINK WITH INFLAMMATION
In in vitro studies, invasive Shigella are engulfed by macrophages, but unlike their non-invasive mutants, they escape from the phagosome and rapidly induce apoptotic death of the macrophage (Zychlinsky, 1992) . This observation has been confirmed in vivo, looking at infection of Peyer's patches in a rabbit ligated loop model of infection. Apoptosis is detected at the background level in areas where infection is carried out with a non invasive mutant, whereas numerous apoptotic cells can be seen if an invasive Shigella is used (Zychlinsky, 1996) . IpaB is required for killing of macrophages. Direct cytotoxicity of IpaB has been demonstrated both by a genetic approach (Zychlinsky, 1994) , and by microinjecting this purified protein into macrophages (Chen, 1996) . The mode of action of IpaB appears to reside essentially in its capacity to bind the interleukin-1 9 (IL-1 9 )-converting enzyme (ICE/Caspase 1), or a related protein (Chen, 1996) 
